Cocrystal PharmaCOCP
13F holders, Q1 2024 (March 31)16holders
1famous investor
$1.41avg. 13F price*
At the end of Q1 2024, 16 institutions reported holding Cocrystal Pharma Inc. (COCP) in their 13F filings. The largest holders were Vanguard Group Inc. ($386K), Renaissance Technologies ($176K) and BlackRock Inc. ($103K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cocrystal Pharma Inc.
- CUSIP
- 19188J409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $7 |
Ownership 16 holders
| Vanguard Group Inc. | 0.00% | No change | 275,656 | $386K |
| Renaissance Technologies | 0.00% | Add +0.7% | 126,028 | $176K |
| BlackRock Inc. | 0.00% | Reduce -0.4% | 73,746 | $103K |
| Geode Capital Management, LLC | 0.00% | No change | 60,432 | $86K |
| Morgan Stanley | 0.00% | Reduce -0.0% | 59,271 | $83K |
| Susquehanna International Group, LLP | 0.00% | Add +50.9% | 52,130 | $75K |
| State Street Corp. | 0.00% | No change | 24,443 | $35K |
| UBS Group AG | 0.00% | Add +12030.5% | 20,258 | $28K |
| Northern Trust Corp. | 0.00% | No change | 12,207 | $17K |
| Bank of America Corp. | 0.00% | Reduce -0.0% | 8,975 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +27.6% | 7,456 | $10K |
| JPMorgan Chase & Co. | 0.00% | Reduce -75.3% | 543 | $776 |
| Vima LLC | 0.00% | Add +2.7% | 231 | $461 |
| Wells Fargo & Company | 0.00% | Add +1.1% | 93 | $130 |
| Nvwm, LLC | 0.00% | No change | 84 | $118 |
| Royal Bank of Canada | 0.00% | Add +466.7% | 51 | $0 |
"% of holder's portfolio" is COCP's weight in each manager's 13F, not the share of Cocrystal Pharma Inc. the manager owns.